Thoughts ? Reads well.....
Imugene lead product HER-Vaxx patent application receives US Notice of Allowance • Imugene’s biggest intellectual property milestone • Patent will give method of composition and method of use protection to 2030 Melbourne, 29 July 2014: Australian biopharmaceutical company Imugene Limited (ASX:IMU) has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for Patent Application 13/389419 (2030 expiry) which protects its HER-Vaxx cancer immunotherapy, currently in development for gastric cancer. The patent titled “Multiepitope Vaccine for HER2/Neu-associated Cancers” protects the method of composition and method of use of Imugene’s HER-Vaxx for the generation of a therapeutic antibody response against HER-2/neu. HER-Vaxx is a proprietary therapeutic cancer immunotherapy that stimulates a polyclonal antibody response to HER-2/neu, the same biomarker targeted by the $US6.9 billion per annum drug Herceptin®. HER-Vaxx has successfully completed a Phase 1 study in breast cancer and the next stage of development will be a Phase 2 study in gastric cancer. Dr Nick Ede, Executive Director Imugene said, “Attaining the key US patent is the biggest milestone for almost every biotechnology company. This adds extra value to HER-Vaxx as this will protect it in the world’s largest pharmaceutical market until 2030.” Gastric or stomach cancer is the second most common cause of cancer-related death in the world and the fourth most commonly diagnosed cancer, with over 1,000,000 new cases diagnosed each year. Contact : Paul A Hopper Dr Nick Ede Executive Chairman Executive Director +1 858 334 5820 (US) +61 400 642 254 +61 406 671 515 (Australia) nede[at]imugene.com receptogen[at]earthlink.net Media contact:
- Forums
- ASX - By Stock
- Ann: HER-Vaxx patent application receives US Notice of Allowance
Thoughts ? Reads well..... Imugene lead product HER-Vaxx patent...
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $768.4M |
Open | High | Low | Value | Volume |
10.5¢ | 10.8¢ | 10.0¢ | $746.7K | 7.120M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
176 | 10004604 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 420568 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
176 | 10004604 | 0.100 |
12 | 525784 | 0.099 |
10 | 716843 | 0.098 |
11 | 640958 | 0.097 |
10 | 772491 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 420568 | 8 |
0.110 | 7967553 | 66 |
0.115 | 6445983 | 53 |
0.120 | 11666760 | 87 |
0.125 | 13968032 | 53 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
10.3¢ |
  |
Change
0.000 ( 2.40 %) |
|||
Open | High | Low | Volume | ||
10.3¢ | 10.5¢ | 10.3¢ | 1930285 | ||
Last updated 15.59pm 28/03/2024 ? |
Featured News
IMU (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online